Ab&B Bio-Tech CO., LTD. JS (HKG:2627)

HKG:2627 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Mar 26, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	27.23	6.05	1.16
Net Debt / Equity Ratio	24.01	5.15	0.95
Net Debt / EBITDA Ratio	-5.54	-3.65	-0.87
Net Debt / FCF Ratio	-3.53	-1.89	-0.60
Asset Turnover	-	0.19	-
Inventory Turnover	-	2.17	-
Quick Ratio	0.32	0.48	0.31
Current Ratio	0.44	0.55	0.40
Return on Equity (ROE)	-	-101.49%	-
Return on Assets (ROA)	-	-11.71%	-
Return on Capital Employed (ROCE)	-33.90%	-36.40%	-73.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.